References
- Chavanas S, Bodemer C, Rochat A et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat. Genet.25(2), 141–142 (2000).
- Comel M. Ichthyosis linearis circumflexa. Dermatologica98(3), 133–136 (1949).
- Netherton EW. A unique case of trichorrhexis invaginata. Arch. Derm.78(4), 483–487 (1958).
- Ong C, Harper J. Netherton’s syndrome. In: Textbook of Pediatric Dermatology. Harper J, Oranje A, Prose N (Eds). Wiley Blackwell Publishers, Oxford, UK, 1359–1366 (2006).
- Bitoun E, Chavanas S, Irvine AD et al. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J. Invest. Dermatol.118(2), 352–361 (2002).
- Descargues P, Deraison C, Bonnart C et al. SPINK5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat. Genet.37(1), 56–65 (2005).
- Descargues P, Deraison C, Prost C et al. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome. J. Invest. Dermatol.126(7), 1622–1632 (2006).
- Bonnart C, Deraison C, Lacroix M et al. Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through FILAGGRIN and lipid misprocessing. J. Clin. Invest.120(3), 871–882 (2010).
- Kawashima I, Tani T, Shimoda K, Takiguchi Y. Characterization of pancreatic elastase II cDNAs: two elastase II mRNAs are expressed in human pancreas. DNA6(2), 163–172 (1987).
- Deraison C, Bonnart C, Lopez F et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol. Biol. Cell18(9), 3607–3619 (2007).
- Shimomura Y, Sato N, Kariya N, Takatsuka S, Ito M. Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules. Br. J. Dermatol.153(5), 1026–1030 (2005).